UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 30

Sortiert nach

Tumor Cell-Free DNA Copy Number Instability Predicts Therapeutic Response to Immunotherapy

Clinical cancer research, 2017-09, Vol.23 (17), p.5074-5081

2017

Link zum Volltext

Verfügbarkeit prüfen

Long-term disease-free survival following comprehensive involved site radiotherapy for oligometastases

Frontiers in oncology, 2023, Vol.13, p.1267626-1267626

2023

Link zum Volltext

Verfügbarkeit prüfen

Multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART)

Journal for immunotherapy of cancer, 2021-08, Vol.9 (8), p.e002990

2021

Link zum Volltext

Verfügbarkeit prüfen

A prospective pilot study of genome-wide exome and transcriptome profiling in patients with small cell lung cancer progressing after first-line therapy

PloS one, 2017-06, Vol.12 (6), p.e0179170-e0179170

2017

Link zum Volltext

Verfügbarkeit prüfen

Association of radiation dose intensity with overall survival in patients with distant metastases

Cancer medicine (Malden, MA), 2021-11, Vol.10 (22), p.7934-7942

2021

Link zum Volltext

Verfügbarkeit prüfen

Evaluation and comparison of two commercially available targeted next-generation sequencing platforms to assist oncology decision making

OncoTargets and therapy, 2015-01, Vol.8 (default), p.959-967

2015

Link zum Volltext

Verfügbarkeit prüfen

795 A multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART)

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A843-A843

2020

Link zum Volltext

Verfügbarkeit prüfen

A phase Ib study of pembrolizumab plus chemotherapy in patients with advanced cancer (PembroPlus)

British journal of cancer, 2017-06, Vol.117 (1), p.33-40

2017

Link zum Volltext

Verfügbarkeit prüfen

Personalized Palliative and Survivorship Care for Patients With Metastatic Cancer Treated With Radiation Therapy

Anticancer research, 2023-04, Vol.43 (4), p.1387

2023

Link zum Volltext

Verfügbarkeit prüfen

Phase 2 trial of epidermal growth factor (EGF) vaccine CIMAvax in combination with pembrolizumab in first line and maintenance setting in advanced non–small cell lung cancer patients

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.TPS2677-TPS2677

2023

Link zum Volltext

Verfügbarkeit prüfen

Liquid nitrogen spray cryotherapy for dysphagia palliation in patients with inoperable esophageal cancer

Gastrointestinal endoscopy, 2018-09, Vol.88 (3), p.447-455

2018

Link zum Volltext

Verfügbarkeit prüfen

Abstract CT134: Phase I/II trial of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinoma

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.CT134-CT134

2017

Link zum Volltext

Verfügbarkeit prüfen

Abstract 624: Evaluation and comparison of two commercially available targeted NGS platforms to assist oncology decision making

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.624-624

2015

Link zum Volltext

Verfügbarkeit prüfen

Abstract A50: Phase Ib/II study of pembrolizumab plus chemotherapy: Initial results of metastatic cancer patients

Molecular cancer therapeutics, 2015-12, Vol.14 (12_Supplement_2), p.A50-A50

2015

Link zum Volltext

Verfügbarkeit prüfen

Palbociclib (P) in patients (pts) with non-small cell lung cancer (NSCLC) with CDKN2A alterations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.9041-9041

2019

Link zum Volltext

Verfügbarkeit prüfen

MA11.10 Prospective Study of Genome-Wide Strexome and Transcriptome Profiling in Patients with Small Cell Lung Cancer Progressing after 1st Line Therapy

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S408-S409

2017

Link zum Volltext

Verfügbarkeit prüfen

Tumor cell-free DNA copy number instability (CNI) to predict therapeutic response to immunotherapy prior to cycle 2

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.3027-3027

2016

Link zum Volltext

Verfügbarkeit prüfen

Tu1585 Cryotherapy in Combination With Systemic Chemotherapy for Gastro-Esophageal Cancer Palliation: Chilling Initial Results

Gastrointestinal endoscopy, 2015-05, Vol.81 (5), p.AB519-AB519

2015

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3138: Changes in tumor cell-free DNA copy number instability (CNI) predict therapeutic response in metastatic cancers

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.3138-3138

2016

Link zum Volltext

Verfügbarkeit prüfen

Combining Genome Change Index (GCI) and liquid biopsy to predict and monitor therapeutic responses

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e22020-e22020

2015

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of contemporary platinum-doublet chemotherapy-modified dose and schedules

Lung cancer management, 2013-10, Vol.2 (5), p.329-332

2013

Link zum Volltext

Verfügbarkeit prüfen

Maintaining clarity: Review of maintenance therapy in non-small cell lung cancer

World journal of clinical oncology, 2014-05, Vol.5 (2), p.103-113

2014

Link zum Volltext

Verfügbarkeit prüfen

Changes of BNP Level and Pulmonary Arterial Pressure during An Acute Sickle Cell Crisis, Comparison with Steady State

Blood, 2008-11, Vol.112 (11), p.2503-2503

2008

Link zum Volltext

Verfügbarkeit prüfen

A STRATEGIC APPROACH TO INCREASE VENOUS THROMBOEMBOLISM PROPHYLAXIS RATE IN MEDICAL PATIENTS USING GUIDELINE IMPLEMENTATION AND EDUCATIONAL INTERVENTION

Chest, 2008-10, Vol.134 (4), p.9

2008

Link zum Volltext

Verfügbarkeit prüfen

Piperacillin Induced Thrombocytopenia in Critical Care Patients as Compared to Non Critical Patients

Blood, 2007-11, Vol.110 (11), p.3916-3916

2007

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(30)

Sprache

Englisch
(30)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Tumor Cell-Free DNA Copy Number Instability Predicts Therapeutic Response to Immunotherapy

Long-term disease-free survival following comprehensive involved site radiotherapy for oligometastases

Multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART)

A prospective pilot study of genome-wide exome and transcriptome profiling in patients with small cell lung cancer progressing after first-line therapy

Association of radiation dose intensity with overall survival in patients with distant metastases

Evaluation and comparison of two commercially available targeted next-generation sequencing platforms to assist oncology decision making

795 A multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART)

A phase Ib study of pembrolizumab plus chemotherapy in patients with advanced cancer (PembroPlus)

Personalized Palliative and Survivorship Care for Patients With Metastatic Cancer Treated With Radiation Therapy

Phase 2 trial of epidermal growth factor (EGF) vaccine CIMAvax in combination with pembrolizumab in first line and maintenance setting in advanced non–small cell lung cancer patients

Liquid nitrogen spray cryotherapy for dysphagia palliation in patients with inoperable esophageal cancer

Abstract CT134: Phase I/II trial of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinoma

Abstract 624: Evaluation and comparison of two commercially available targeted NGS platforms to assist oncology decision making

Abstract A50: Phase Ib/II study of pembrolizumab plus chemotherapy: Initial results of metastatic cancer patients

Palbociclib (P) in patients (pts) with non-small cell lung cancer (NSCLC) with CDKN2A alterations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study

MA11.10 Prospective Study of Genome-Wide Strexome and Transcriptome Profiling in Patients with Small Cell Lung Cancer Progressing after 1st Line Therapy

Tumor cell-free DNA copy number instability (CNI) to predict therapeutic response to immunotherapy prior to cycle 2

Tu1585 Cryotherapy in Combination With Systemic Chemotherapy for Gastro-Esophageal Cancer Palliation: Chilling Initial Results

Abstract 3138: Changes in tumor cell-free DNA copy number instability (CNI) predict therapeutic response in metastatic cancers

Combining Genome Change Index (GCI) and liquid biopsy to predict and monitor therapeutic responses

Evaluation of contemporary platinum-doublet chemotherapy-modified dose and schedules

Maintaining clarity: Review of maintenance therapy in non-small cell lung cancer

Changes of BNP Level and Pulmonary Arterial Pressure during An Acute Sickle Cell Crisis, Comparison with Steady State

A STRATEGIC APPROACH TO INCREASE VENOUS THROMBOEMBOLISM PROPHYLAXIS RATE IN MEDICAL PATIENTS USING GUIDELINE IMPLEMENTATION AND EDUCATIONAL INTERVENTION

Piperacillin Induced Thrombocytopenia in Critical Care Patients as Compared to Non Critical Patients

Suchergebnisse filtern